Mizuho analyst Steven Valiquette raised the firm’s price target on Cardinal Health (CAH) to $235 from $222 and keeps an Outperform rating on the shares. The firm updated the company’s model post the earnings report.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAH:
- Cardinal Health’s Earnings Call Highlights Broad-Based Upswing
- Early notable gainers among liquid option names on February 5th
- Morning Movers: Ralph Lauren and Qualcomm sink after earnings
- Cardinal Health posts strong Q2 results, raises guidance
- Cardinal Health ups FY26 EPS view to $10.15-$10.35 from $10.00, consensus $10.02